entity

CNS

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about CNS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections
2Hypotheses
5Analyses
0Outgoing
7Incoming

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

B-Lymphocytes (CNS)

cell · 663 words

cbs-psp-daily-action-plan

therapeutic · 30834 words

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

Clinical Management Guide for CBS/PSP

therapeutic · 15224 words

Progressive Supranuclear Palsy (PSP)

disease · 12907 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (7)

SourceRelationTypeStr
BI-hTFR1mediatesprotein0.90
BDNFexpressed_inprotein0.87
JEVinfectsvirus0.80
MICROGLIAexpressed_incell_type0.76
MSregulatesdisease0.72

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
MFSD2A-Targeted Lysophosphatidylcholine-SPM Conjugates as CN 0.552 neuropharmacology What determines blood-brain barrier pene
Pharmacogenomic CNS Drug Optimization Platform 0.534 neurodegeneration How do neurodegeneration gene expression

Mentioning Analyses (5)

Scientific analyses that reference this entity

How do synthetic EVs achieve brain-specific targeting while avoiding reticuloend

drug delivery | 2026-04-15 | 0 hypotheses

What determines blood-brain barrier penetration kinetics for specialized pro-res

neuropharmacology | 2026-04-13 | 2 hypotheses Top: 0.552

What are the specific molecular mechanisms by which AQP4 dysfunction contributes

neurodegeneration | 2026-04-07 | 0 hypotheses

Senescent cell clearance as neurodegeneration therapy

neurodegeneration | 2026-04-04 | 0 hypotheses

Systemic immune profiling and peripheral immune contributions to neurodegenerati

neurodegeneration | 2026-04-04 | 0 hypotheses

Related Papers (7)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Geniposidic Acid Targeting FXR "S332 and H447" Mediated Conformational Change to [PMID:39998442] Fan M, Xu Y, Wu B, Long J, Liu C et al. Adv Sci (Weinh) 2025 0
Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization a [PMID:36068470] Cacabelos R, Naidoo V, Martínez-Iglesias Methods Mol Biol 2022 0
Cannabis sativa: Much more beyond Δ(9)-tetrahydrocannabinol. [PMID:32335286] Alves P, Amaral C, Teixeira N, Correia-d Pharmacol Res 2020 0
The pharmacogenomics of valproic acid. [PMID:28878340] Zhu MM, Li HL, Shi LH, Chen XP, Luo J et J Hum Genet 2017 0
Ocular pharmacology. [PMID:26360129] Novack GD, Robin AL J Clin Pharmacol 2016 0
1,4-Dihydropyridine scaffold in medicinal chemistry, the story so far and perspe [PMID:22709009] Carosati E, Ioan P, Micucci M, Broccatel Curr Med Chem 2012 0
ABC transporters and cytochromes P450 in the human central nervous system: influ [PMID:20843279] Dutheil F, Jacob A, Dauchy S, Beaune P, Expert Opin Drug Metab Toxicol 2010 0